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Introduction: Here we present the case of a patient with fatal pulmonary histoplasmosis who presented with
extensive necrotizing and cavitating pneumonia. To the best of our knowledge, this case report is the first to
describe this presentation in a patient with no known immunosuppression.
Case presentation: A 45-year-old Caucasian woman, a smoker from southeastern Minnesota, presented to our hospital
with progressive dyspnea, fatigue and weight loss over the course of several months. Her medical history included type
2 diabetes mellitus, systemic hypertension and chronic opioid use for back pain. She did not have any recent travel
history, and she had no unusual hobbies or risk factors for human immunodeficiency virus. When she was admitted
to our intensive care unit, she was in hypoxic respiratory failure, thus we intubated her and placed her on mechanical
ventilation. A computed tomographic scan of the chest revealed extensive areas of pulmonary necrosis with diffuse
bilateral cavitation and lung destruction, which were especially prominent in the upper and middle lung fields.
Bronchoalveolar lavage confirmed growth of Histoplasma capsulatum as the sole isolated pathogen. No other
infectious agents were identified in blood, bronchoalveolar lavage, sputum or urine samples. Her condition worsened
over the next 24 to 48 hours, with progressive multi-organ failure in spite of aggressive antibiotic and antifungal therapy.
Her family elected to withdraw supportive care, and she died shortly thereafter.
Conclusion: This case demonstrates a novel manifestation of histoplasmosis associated with extensive lung necrosis and
cavitation. This report is of particular interest to pulmonologists and intensivists and underscores the importance of
maintaining suspicion for mycotic disease in patients who have atypical presentations but live in an endemic area.
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Necrotizing pneumonia is a morbid and potentially fatal
complication of pulmonary infection characterized by
progressive necrosis of lung parenchyma. Most common
causative organisms are bacteria, including Staphylo-
coccus aureus, Streptococcus pneumonia and Klebsiella
pneumoniae. Pseudomonas aeruginosa, Haemophilus influ-
enzae, Escherichia coli, Acinetobacter baumannii, and
anaerobic pathogens have also been reported to cause nec-
rotizing pneumonia [1]. Fungi are a less common cause.
For example, Aspergillus species can cause necrotizing
pneumonia in immunocompromised hosts, particularly
those patients who have received hematopoietic or solid
organ transplants [2,3]. Histoplasma capsulatum can cause* Correspondence: schiavo.dante@mayo.edu
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reproduction in any medium, provided the orasymptomatic disease, acute pulmonary histoplasmosis or
chronic pulmonary histoplasmosis. Chronic cavitary pul-
monary histoplasmosis can be associated with fibrotic
and cavitary changes, but this typically occurs in patients
with underlying structural lung disease [4]. Here we
present a case of histoplasmosis presenting as rapidly pro-
gressive necrotizing pneumonia in a patient with relatively
little changes in baseline lung architecture and no known
immunosuppression.
Case presentation
A 45-year-old Caucasian woman, a smoker with a history
of type 2 diabetes mellitus, was admitted to our hospital
with a 3-month history of progressive exertional dyspnea
associated with malaise, cough productive of pink-tinged
sputum and a 100-lb unintentional weight loss over the
preceding year. She did not use alcohol or illicit drugs,
was receiving disability income because of back pain,l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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Minnesota, did not have pets or animal exposure and had
no history of exotic travel.
Her physical examination showed a cachectic, toxic-
appearing woman who appeared remarkably older than
her actual age. Her vital signs were heart rate 134 beats per
minute (bpm), blood pressure 118/74mmHg, respiratory
rate 32 breaths/min, oxygen saturation 78% on room air
and body temperature 37.0°C. She had a weak cough, and
auscultation of the chest revealed diffusely reduced breath
sounds bilaterally with faint inspiratory crackles. There was
no clubbing. Her cardiac examination revealed tachycardia
but no murmurs.
Laboratory studies showed neutrophilic leukocytosis
and low serum potassium, creatinine and albumin levels.
The results of an arterial blood gas study on 2L/min
of supplemental oxygen were pH 7.38, partial pressure
of carbon dioxide in arterial blood 24mmHg, partial
pressure of oxygen in arterial blood 71mmHg and bi-
carbonate 14mmol/L. Urinalysis was unremarkable. Anti-
body testing for human immunodeficiency virus (HIV)
type 1 and HIV type 2 was negative. Serum immuno-
globulin (Ig) levels (IgG, IgM and IgA) were within nor-
mal limits. The results of serum protein electrophoresis
showed no monoclonal proteins, and a connective tissue
panel for rheumatologic disease was negative. Chest
radiography showed marked, diffuse, bilateral interstitial
and alveolar opacities with slight upper-lobe predomin-
ance (Figure 1). High-resolution computed tomography
(CT) of the chest revealed extensive bilateral interstitialFigure 1 Anteroposterior chest radiograph taken at time of
admission. This image shows diffuse bilateral interstitial and
airspace opacities.thickening with ground-glass and cavitary opacities asso-
ciated with parenchymal destruction that was most pro-
nounced in the upper lungs (Figure 2A and 2B). A CT
scan of the chest performed 9 months earlier (Figure 3)
because of her weight loss was normal, except for subtle
centrilobular and subpleural emphysema in the upper
lobes.
The patient underwent bronchoalveolar lavage (BAL),
and specimens were sent for microbiologic and cytologic
analysis. She was empirically started on vancomycin,
cefepime, levofloxacin and, later, amphotericin B. Her
condition progressively deteriorated after intensive care
unit (ICU) admission. She developed septic shock requir-
ing vasopressors (norepinephrine 0.9μg/kg/min and vaso-
pressin 0.03U/min) and progressive respiratory failure
requiring mechanical ventilation. Her Sequential Organ
Function Assessment Score increased from 1 to 11 by hos-
pital day 3, suggesting a poor prognosis for recovery [5].
The patient’s family decided to withdraw support, and she
died on hospital day three.Figure 2 Computed tomographic scan of the patient’s chest
at time of admission. (A) This image shows bilateral interstitial
thickening and airspace destruction at the upper lung zones.
(B) Ground-glass and cavitary opacities can be observed in the
lower lung zones.
Figure 3 Computed tomographic scan of the chest taken 9
months prior to admission. This image shows a small cluster of
emphysema at the medial left upper lobe, but otherwise the lung
parenchyma is normal.
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negative. Polymerase chain reaction testing for Pneumo-
cystis jiroveci, influenza, adenovirus, respiratory syncytial
virus, Legionella and Mycobacterium tuberculosis was
negative. The patient’s histoplasma serology showed ele-
vated complement fixation titers to both mycelial phase
(1:512) and yeast phase (1:128), and an immunodiffusion
assay showed the presence of H and M bands. BAL fungal
cultures grew many H. capsulatum organisms.
Discussion
Necrotizing pneumonia denotes infection-related pulmon-
ary consolidation complicated by necrosis or gangrene of
the lung tissue [6]. Although the term necrotizing pneumo-
nia refers to a non-specific process potentially seen in
multiple different lung infections, most cases described in
the literature have been attributable to bacterial patho-
gens. A recent review identified S. aureus, S. pneumoniae
and K. pneumoniae as the most common pathogens caus-
ing necrotizing pneumonia [1]. Tseng and colleagues [7]
conducted a review of 30 pediatric patients with clinical,
radiologic and histologic evidence of necrotizing pneumo-
nia. In their series, most patients either had infection with
S. pneumoniae or S. aureus or no causative microorganism
that could be identified. In five patients, however, only a
non-bacterial pathogen was isolated from lung tissue,
including Mucor species and Aspergillus fumigatus.
All patients with non-bacterial pathogens isolated were
immunosuppressed. Subsequent studies have also sug-
gested that non-bacterial infectious causes for lung necro-
sis are more common in immunocompromised patients
[8,9]. Our patient was not known to be immunosup-
pressed. She had no immunosuppressing conditions or
medication exposure.Although H. capsulatum is common in the patient’s
geographic region, our suspicion for the presence of this
organism was initially limited because of the atypical
presentation. Chronic pulmonary histoplasmosis can be
associated with cavitary changes but is usually seen in
older patients and in individuals with significant
underlying parenchymal disease [4]. The chest CT in
such patients typically demonstrates interstitial infil-
trates, along with pre-existing changes of emphysema
and foci of cavitation or destruction with thickened walls
[10]. Our patient was relatively young. A CT scan of the
chest performed 9 months prior to her presentation to
our hospital showed little parenchymal change. As such,
we felt her presentation would be atypical for fungal
pneumonia, and the initial empiric antimicrobial regimen
covered primarily bacterial pathogens. After she experi-
enced several hours of clinical deterioration, liposomal
amphotericin B was added.
Direct tissue analysis using microscopic stains and cul-
tures for additional organisms could not be performed.
However, we think that the many H. capsulatum organ-
isms isolated on deep respiratory culture and the very high
serology titers strongly implicate this organism as a patho-
gen that contributed to the patient’s fatal pneumonia.
Conclusion
This patient’s presentation was unique in that H. capsu-
latum was associated with rapidly progressive lung necro-
sis in an apparently immunocompetent host. This case
highlights the importance of including non-bacterial path-
ogens in the differential diagnosis of necrotizing pneumo-
nia, particularly in patients who live in areas with common
endemic mycoses.
Consent
Prior to her death, written informed consent was obtained
from the patient for publication of this case report and any
accompanying images. A copy of the written consent is
available for review by the Editor-in-Chief of this journal.
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